Delivery Order SPE2DB20D1100-SPE2DB25FC7X8

Award Date 6/9/25
Potential Completion Date 6/10/25
Potential Value $9.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,586.44 firm fixed-price delivery order contract is for the supply of "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML" medical products. The contract has an ultimate completion date of February 3, 2025. While the original solicitation was not provided, the award indicates that this is part of a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,812.12 firm fixed-price delivery order is for the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a medical product. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,701.84, is a Firm Fixed Price Delivery Order for the supply of "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML" medical products. The contract has an ultimate completion date of January 29, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,457.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a period of performance through April 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,707.20 firm fixed-price delivery order is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a medical product. The contract has an ultimate completion date of January 15, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, serving as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,355.17 firm-fixed-price delivery order contract is for the supply of "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML" medical products. The contract has an ultimate completion date of October 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,525.20, is a delivery order for "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML" medical products. It is a firm fixed-price contract with an ultimate completion date of January 13, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $9,108.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of May 20, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corporation holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,655.29 firm fixed-price delivery order contract has an ultimate completion date of March 21, 2025. The contract covers the provision of medical products, including the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award, valued at $1,792.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4568062174 - ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, with a completion date of April 29, 2025. The contract is a firm fixed-price arrangement and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FC7X8
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,763.19, is a firm fixed-price delivery order for ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of June 10, 2025.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This IDC allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The contract award described is not set-aside and represents open competition.

Generated 9/8/25, 9:54 AM